Systemic Lupus Erythematosus
- Real-World Risk Factors for Severe COVID-19 in Systemic Lupus Erythematosus
- Numerous Novel Therapeutics for Lupus Nephritis Under Investigation
- Phase 3 Trial Offers Compelling Evidence for Voclosporin Supplementation Among Patients With Lupus Nephritis
- Incidence of Systemic Lupus Erythematosus Greater Among Younger Women vs Men in Sweden
- Early Kidney Biopsy Necessary During Early-Onset Urinary Abnormalities to Detect Lupus Nephritis
- Nonadherence to HCQ Associated With Flares, Damage, and Mortality in SLE
- Caution Urged When Using Oral Corticosteroids for Treatment of Systemic Lupus Erythematosus
- Neuropsychiatric SLE Less Frequent Among Patients With Late- vs Early-Onset Lupus
- Poor Outcomes in SLE Potentially Modifiable by Eliminating Cost Concerns
- SLE-Derived Algorithms May Be Inconsistent When Assessing Adverse Pregnancy Outcomes Among Racial Groups
- SLE Treatment With OCS Associated With Increased Financial Burden and Resource Utilization
- Lupus Nephritis Flares Still Occur After Dialysis Initiation
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
